PUNE, India, November 24, 2016 /PRNewswire/ --
According to a new market research report "High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021", published by MarketsandMarkets, the global market is expected to reach USD 18.83 Billion by 2021 from USD 12.23 Billion in 2016, at a CAGR of 7.8% from 2016 to 2021.
Browse 237 market data Tables and 39 Figures spread through 252 Pages and in-depth TOC on "High-Throughput Screening Market"
Early buyers will receive 10% customization on this report.
The major factors driving the growth of this market include growing adoption of open innovative models in pharmaceutical and biotechnology companies and increasing R&D spending. Technological advancements in the HTS technique & rising government funding are some other factors driving the growth of this market. Emerging markets and growing research activities in toxicology and stem cells are expected to provide further growth opportunities for players operating in the market. Label-free technology and automation and miniaturization of HTS techniques are the key trends of this market. However, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period.
This market is segmented on the basis of product and service, technology, application end user and regions. Based on product and service, the global High-Throughput Screening Market is segmented into consumables and reagents, instruments, & software and services. In 2015, consumables and reagents accounted for the largest share of the global high-throughput screening products and services market. The availability of a wide range of reagents and continual product developments and innovations contributes to their largest share in HTS products and services market.
Download The Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=134981950
Furthermore, on the basis of end users, the market is classified into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs) and other end users. The other end users segment includes hospitals & clinics, and food, agriculture, and environmental industries. The pharmaceutical and biotechnology companies segment accounted for the largest share in the global HTS market, by end users. The extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications is the major factor driving the growth of this market.
In 2015, North America accounted for the largest share of the global High-Throughput Screening Market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the large spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and the presence of major companies in this region. However, Asia-Pacific and Latin American regions provide wide scope for the High-Throughput Screening Market growth. This is mainly attributed to the increasing R&D spending; growing trend of outsourcing drug discovery services; growing public-private partnerships; and increasing government funding.
Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and Tecan Group Ltd. (Switzerland)held the major share of the High-Throughput Screening Market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are Merck Millipore (U.S.), Bio-Rad laboratories (U.S.), Hamilton Company (U.S.), Axxam S.p.A. (Italy) and Aurora Biomed (Canada).
Browse Related Reports:
3D CELL CULTURE MARKET by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021.
CELL-BASED ASSAYS MARKET By Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Knowledgestore.asp
Contact: Mr. Rohan MarketsandMarkets 701 Pike Street Suite 2175, Seattle, WA 98101, United States Telephone No: 1-888-600-6441. Email: firstname.lastname@example.org
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Subscribe to our Free Newsletters!
Do fad diets really work? Here are some disadvantages and side-effects of going on a fad diet. ...
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Inborn errors of metabolism are genetic disorders that hamper the body''s metabolism resulting in ...View All